{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T01:29:41Z","timestamp":1791941381808,"version":"4.3.4"},"reference-count":325,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bcp.2026.117813","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T16:12:18Z","timestamp":1771431138000},"page":"117813","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Sarcopenia: An overview of emerging therapies and pathophysiological insights in age-related skeletal muscle decline"],"prefix":"10.1016","volume":"248","author":[{"given":"Deepak","family":"Mishra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8174-0574","authenticated-orcid":false,"given":"Lucy","family":"Mohapatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"100","key":"10.1016\/j.bcp.2026.117813_b0005","article-title":"Muscle aging and sarcopenia: the pathology, etiology, and most promising therapeutic targets","volume":"1","author":"Grima-Terr\u00e9n","year":"2024","journal-title":"Mol. Aspects Med."},{"issue":"7","key":"10.1016\/j.bcp.2026.117813_b0010","doi-asserted-by":"crossref","first-page":"e883","DOI":"10.1016\/S2214-109X(19)30172-X","article-title":"The escalating global burden of serious health-related suffering: projections to 2060 by world regions, age groups, and health conditions","volume":"7","author":"Sleeman","year":"2019","journal-title":"Lancet Glob. Health"},{"issue":"1","key":"10.1016\/j.bcp.2026.117813_b0015","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1080\/13642987.2017.1390310","article-title":"Enablement and positive ageing: a human rights-based approach to older people and changing demographics","volume":"22","author":"Love","year":"2018","journal-title":"Int J Hum Rights"},{"issue":"123","key":"10.1016\/j.bcp.2026.117813_b0020","article-title":"Prevalence and factors associated with sarcopenia among Brazilian older adults: an exploratory network analysis","volume":"1","author":"Franco","year":"2024","journal-title":"Arch. Gerontol. Geriatr."},{"issue":"1","key":"10.1016\/j.bcp.2026.117813_b0025","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1152\/physrev.00061.2017","article-title":"Sarcopenia: aging-related loss of muscle mass and function","volume":"99","author":"Larsson","year":"2019","journal-title":"Physiol. Rev."},{"issue":"65","key":"10.1016\/j.bcp.2026.117813_b0030","article-title":"Sarcopenia\u2013Molecular mechanisms and open questions","volume":"1","author":"Wiedmer","year":"2021","journal-title":"Ageing Res. Rev."},{"issue":"11","key":"10.1016\/j.bcp.2026.117813_b0035","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/JCMA.0000000000001164","article-title":"Sarcopenia in the era of precision health: toward personalized interventions for healthy longevity","volume":"87","author":"Chen","year":"2024","journal-title":"J. Chin. Med. Assoc."},{"issue":"5","key":"10.1016\/j.bcp.2026.117813_b0040","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.exger.2013.02.012","article-title":"The decline in skeletal muscle mass with aging is mainly attributed to a reduction in type II muscle fiber size","volume":"48","author":"Nilwik","year":"2013","journal-title":"Exp. Gerontol."},{"issue":"4","key":"10.1016\/j.bcp.2026.117813_b0045","doi-asserted-by":"crossref","DOI":"10.1111\/apha.14012","article-title":"Slow or fast: Implications of myofibre type and associated differences for manifestation of neuromuscular disorders","volume":"238","author":"Lloyd","year":"2023","journal-title":"Acta Physiol."},{"issue":"121","key":"10.1016\/j.bcp.2026.117813_b0050","article-title":"Immunosenescence as a convergence pathway in neurodegeneration","volume":"1","author":"Mohapatra","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bcp.2026.117813_b0055","first-page":"1","article-title":"Advances in sarcopenia: mechanisms, therapeutic targets, and intervention strategies","volume":"9","author":"Zheng","year":"2024","journal-title":"Arch. Pharm. Res."},{"issue":"6","key":"10.1016\/j.bcp.2026.117813_b0060","first-page":"208","article-title":"The neuromuscular junction: aging at the crossroad between nerves and muscle","volume":"11","author":"Gonzalez-Freire","year":"2014","journal-title":"Front. Aging Neurosci."},{"issue":"7","key":"10.1016\/j.bcp.2026.117813_b0065","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1007\/s11739-023-03339-z","article-title":"Sarcopenia, a condition shared by various diseases: can we alleviate or delay the progression?","volume":"18","author":"Tarantino","year":"2023","journal-title":"Intern. Emerg. Med."},{"issue":"6","key":"10.1016\/j.bcp.2026.117813_b0070","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.3390\/nu12061755","article-title":"Nutrition and sarcopenia\u2014what do we know?","volume":"12","author":"Ganapathy","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.bcp.2026.117813_b0075","first-page":"1","article-title":"Nutrition in the prevention and treatment of skeletal muscle ageing and sarcopenia: a single nutrient, a whole food and a whole diet approach","volume":"17","author":"Granic","year":"2024","journal-title":"Proc. Nutr. Soc."},{"issue":"4","key":"10.1016\/j.bcp.2026.117813_b0080","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.3390\/clinpract14040117","article-title":"Dietary Protein and Physical Exercise for the Treatment of Sarcopenia","volume":"14","author":"Nasso","year":"2024","journal-title":"Clin Pract"},{"issue":"2","key":"10.1016\/j.bcp.2026.117813_b0085","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s40266-023-01093-7","article-title":"The Current Landscape of Pharmacotherapies for Sarcopenia","volume":"41","author":"Bahat","year":"2024","journal-title":"Drugs Aging"},{"key":"10.1016\/j.bcp.2026.117813_b0090","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00223-015-0022-5","article-title":"Pharmacologic options for the treatment of sarcopenia","volume":"98","author":"Morley","year":"2016","journal-title":"Calcif. Tissue Int."},{"issue":"5","key":"10.1016\/j.bcp.2026.117813_b0095","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.3390\/nu12051293","article-title":"Sarcopenia: a contemporary health problem among older adult populations","volume":"12","author":"Papadopoulou","year":"2020","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.bcp.2026.117813_b0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cger.2010.08.009","article-title":"The frailty syndrome: definition and natural history","volume":"27","author":"Xue","year":"2011","journal-title":"Clin. Geriatr. Med."},{"issue":"17","key":"10.1016\/j.bcp.2026.117813_b0105","article-title":"A comprehensive review of stroke-related signaling pathways and treatment in western medicine and traditional chinese medicine","volume":"7","author":"Chen","year":"2023","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bcp.2026.117813_b0110","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2147\/IJWH.S340537","article-title":"Sarcopenia in menopausal women: current perspectives","volume":"23","author":"Buckinx","year":"2022","journal-title":"Int. J. Womens Health"},{"issue":"1","key":"10.1016\/j.bcp.2026.117813_b0115","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3390\/jcm11010129","article-title":"Association of sarcopenia with osteopenia and osteoporosis in community-dwelling older Korean adults: a cross-sectional study","volume":"11","author":"Lee","year":"2021","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.bcp.2026.117813_b0120","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/jcsm.12160","article-title":"Sarcopenia and physical independence in older adults: the independent and synergic role of muscle mass and muscle function","volume":"8","author":"Dos Santos","year":"2017","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"106","key":"10.1016\/j.bcp.2026.117813_b0125","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.exger.2018.02.023","article-title":"Human neuromuscular aging: sex differences revealed at the myocellular level","volume":"1","author":"Roberts","year":"2018","journal-title":"Exp Geronto"},{"issue":"6","key":"10.1016\/j.bcp.2026.117813_b0130","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/BOR.0b013e328358d59b","article-title":"Sarcopenia in older adults","volume":"24","author":"Walston","year":"2012","journal-title":"Curr. Opin. Rheumatol."},{"issue":"11","key":"10.1016\/j.bcp.2026.117813_b0135","doi-asserted-by":"crossref","first-page":"568","DOI":"10.3389\/fendo.2020.00568","article-title":"Diabetes and sarcopenic obesity: pathogenesis, diagnosis, and treatments","volume":"25","author":"Wang","year":"2020","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bcp.2026.117813_b0140","doi-asserted-by":"crossref","first-page":"809","DOI":"10.2165\/00007256-200434120-00002","article-title":"Effects of aging on muscle fibre type and size","volume":"34","author":"Deschenes","year":"2004","journal-title":"Sports Med."},{"issue":"2","key":"10.1016\/j.bcp.2026.117813_b0145","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000452499","article-title":"Testosterone deficiency and testosterone treatment in older men","volume":"63","author":"Saad","year":"2017","journal-title":"Gerontology"},{"issue":"15","key":"10.1016\/j.bcp.2026.117813_b0150","doi-asserted-by":"crossref","first-page":"5236","DOI":"10.3390\/ijms21155236","article-title":"Role of age-related mitochondrial dysfunction in sarcopenia","volume":"21","author":"Ferri","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2026.117813_b0155","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1600-0838.2009.01084.x","article-title":"Role of the nervous system in sarcopenia and muscle atrophy with aging: strength training as a countermeasure","volume":"20","author":"Aagaard","year":"2010","journal-title":"Scand. J. Med. Sci. Sports"},{"issue":"67","key":"10.1016\/j.bcp.2026.117813_b0160","article-title":"The emerging role of the sympathetic nervous system in skeletal muscle motor innervation and sarcopenia","volume":"1","author":"Delbono","year":"2021","journal-title":"Ageing Res. Rev."},{"issue":"11","key":"10.1016\/j.bcp.2026.117813_b0165","doi-asserted-by":"crossref","first-page":"5787","DOI":"10.1007\/s00415-022-11268-8","article-title":"Sarcopenia and nervous system disorders","volume":"269","author":"Yang","year":"2022","journal-title":"J. Neurol."},{"issue":"7","key":"10.1016\/j.bcp.2026.117813_b0170","first-page":"157","volume":"169","author":"Sarcopenia","year":"2019","journal-title":"Wien. Med. Wochenschr."},{"issue":"4","key":"10.1016\/j.bcp.2026.117813_b0175","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/jgs.14722","article-title":"Effects of different types of exercise on body composition, muscle strength, and IGF\u20101 in the elderly with sarcopenic obesity","volume":"65","author":"Chen","year":"2017","journal-title":"J. Am. Geriatr. Soc."},{"issue":"3","key":"10.1016\/j.bcp.2026.117813_b0180","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.eurger.2015.12.016","article-title":"Physiological and architectural changes in the ageing muscle and their relation to strength and function in sarcopenia","volume":"7","author":"Perkisas","year":"2016","journal-title":"Eur Geriatr Med"},{"issue":"9","key":"10.1016\/j.bcp.2026.117813_b0185","article-title":"Sarcopenia and endocrine ageing: are they related?","volume":"14","author":"Gupta","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.bcp.2026.117813_b0190","doi-asserted-by":"crossref","DOI":"10.1530\/JOE-15-0533","article-title":"Insulin resistance and sarcopenia: mechanistic links between common co-morbidities","author":"Cleasby","year":"2016","journal-title":"J. Endocrinol."},{"issue":"12","key":"10.1016\/j.bcp.2026.117813_b0195","doi-asserted-by":"crossref","first-page":"5766","DOI":"10.1210\/jc.2003-030604","article-title":"Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam","volume":"88","author":"Visser","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.bcp.2026.117813_b0200","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/gerona\/63.5.536","article-title":"Altered growth hormone, cortisol, and leptin secretion in healthy elderly persons with sarcopenia and mixed body composition phenotypes","volume":"63","author":"Waters","year":"2008","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"6","key":"10.1016\/j.bcp.2026.117813_b0205","first-page":"693","article-title":"Sarcopenic obesity: definition, cause and consequences","volume":"11","author":"Stenholm","year":"2008","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"issue":"2","key":"10.1016\/j.bcp.2026.117813_b0210","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/jcsm.12901","article-title":"Pathogenesis of sarcopenia and the relationship with fat mass: descriptive review","volume":"13","author":"Li","year":"2022","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"1","key":"10.1016\/j.bcp.2026.117813_b0215","article-title":"MicroRNA\u2010Regulated Proinflammatory Cytokines in Sarcopenia","volume":"2016","author":"Fan","year":"2016","journal-title":"Mediators Inflamm."},{"issue":"10","key":"10.1016\/j.bcp.2026.117813_b0220","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.3945\/jn.116.230912","article-title":"Inflammaging and skeletal muscle: can protein intake make a difference?","volume":"146","author":"Draganidis","year":"2016","journal-title":"J. Nutr."},{"issue":"13","key":"10.1016\/j.bcp.2026.117813_b0225","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.2174\/0929867326666181129095309","article-title":"Role of pro-inflammatory cytokines in regulation of skeletal muscle metabolism: a systematic review","volume":"27","author":"Sharma","year":"2020","journal-title":"Curr. Med. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2026.117813_b0230","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3390\/ijms20030647","article-title":"Mechanisms underlying metabolic syndrome-related sarcopenia and possible therapeutic measures","volume":"20","author":"Rubio-Ruiz","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.bcp.2026.117813_b0235","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.exger.2006.08.011","article-title":"Skeletal muscle apoptosis, sarcopenia and frailty at old age","volume":"41","author":"Marzetti","year":"2006","journal-title":"Exp. Gerontol."},{"issue":"6","key":"10.1016\/j.bcp.2026.117813_b0240","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.exger.2005.04.003","article-title":"Apoptosis in muscle atrophy: relevance to sarcopenia","volume":"40","author":"Dupont-Versteegden","year":"2005","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.bcp.2026.117813_b0245","unstructured":"Lombardo M, Boaria A, Aulisa G, Padua E, Annino G, Pratesi A, Caprio M, Iellamo F, Bellia A. Sarcopenic obesity: etiology and lifestyle therapy. Eur Rev Med Pharmacol Sci. 2019 Aug 15; 23(16). https:\/\/doi.org\/10.26355\/eurrev_201908_18761."},{"key":"10.1016\/j.bcp.2026.117813_b0250","doi-asserted-by":"crossref","unstructured":"Ligibel JA, Schmitz KH, Berger NA. Sarcopenia in aging, obesity, and cancer. Transl Cancer Res. 2020 Sep; 9(9):5760. https:\/\/doi.org\/10.21037\/tcr-2019-eaoc-05.","DOI":"10.21037\/tcr-2019-eaoc-05"},{"issue":"1","key":"10.1016\/j.bcp.2026.117813_b0255","first-page":"38","article-title":"Current nutritional recommendations and novel dietary strategies to manage sarcopenia","volume":"2","author":"Calvani","year":"2013","journal-title":"J. Frailty Aging"},{"issue":"3","key":"10.1016\/j.bcp.2026.117813_b0260","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3390\/nu13030761","article-title":"Sarcopenia, malnutrition, and cachexia: adapting definitions and terminology of nutritional disorders in older people with cancer","volume":"13","author":"Meza-Valderrama","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.bcp.2026.117813_b0265","first-page":"1","article-title":"Anorexia of ageing: pathway to frailty and sarcopenia","volume":"1","author":"Merchant","year":"2022","journal-title":"J. Nutr. Health Aging"},{"issue":"7","key":"10.1016\/j.bcp.2026.117813_b0270","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/jbmr.3713","article-title":"Nonalcoholic fatty liver disease in the Rotterdam study: about muscle mass, sarcopenia, fat mass, and fat distribution","volume":"34","author":"Alferink","year":"2019","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bcp.2026.117813_b0275","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.archger.2014.02.009","article-title":"Sarcopenia, physical rehabilitation and functional outcomes of patients in a subacute geriatric care unit","volume":"59","author":"S\u00e1nchez-Rodr\u00edguez","year":"2014","journal-title":"Arch. Gerontol. Geriatr."},{"issue":"3","key":"10.1016\/j.bcp.2026.117813_b0280","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.3390\/ijms24032415","article-title":"Fiber-type shifting in sarcopenia of old age: proteomic profiling of the contractile apparatus of skeletal muscles","volume":"24","author":"Dowling","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.bcp.2026.117813_b0285","doi-asserted-by":"crossref","first-page":"642","DOI":"10.3390\/biom9110642","article-title":"Muscular atrophy and sarcopenia in the elderly: is there a role for creatine supplementation?","volume":"9","author":"Dolan","year":"2019","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.bcp.2026.117813_b0290","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1038\/sj.ejcn.1601024","article-title":"Sarcopenia and its implications for the elderly","volume":"54","author":"Roubenoff","year":"2000","journal-title":"Eur. J. Clin. Nutr."},{"issue":"4","key":"10.1016\/j.bcp.2026.117813_b0295","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.arr.2009.05.003","article-title":"The impact of sarcopenia and exercise training on skeletal muscle satellite cells","volume":"8","author":"Snijders","year":"2009","journal-title":"Ageing Res. Rev."},{"issue":"13","key":"10.1016\/j.bcp.2026.117813_b0300","article-title":"Contribution of muscle satellite cells to sarcopenia","volume":"12","author":"Huo","year":"2022","journal-title":"Front. Physiol."},{"issue":"18","key":"10.1016\/j.bcp.2026.117813_b0305","doi-asserted-by":"crossref","first-page":"6732","DOI":"10.3390\/ijms21186732","article-title":"Regulation of microRNAs in satellite cell renewal, muscle function, sarcopenia and the role of exercise","volume":"21","author":"Fochi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"35","key":"10.1016\/j.bcp.2026.117813_b0310","first-page":"23","article-title":"Inhibiting uptake of extracellular vesicles derived from senescent bone marrow mesenchymal stem cells by muscle satellite cells attenuates sarcopenia","volume":"1","author":"Dai","year":"2022","journal-title":"J Orthop Transl"},{"issue":"6","key":"10.1016\/j.bcp.2026.117813_b0315","first-page":"246","article-title":"Regulation of satellite cell function in sarcopenia","volume":"22","author":"Alway","year":"2014","journal-title":"Front. Aging Neurosci."},{"issue":"77","key":"10.1016\/j.bcp.2026.117813_b0320","article-title":"Searching for the link between inflammaging and sarcopenia","volume":"1","author":"Wang","year":"2022","journal-title":"Ageing Res. Rev."},{"issue":"23","key":"10.1016\/j.bcp.2026.117813_b0325","doi-asserted-by":"crossref","first-page":"15039","DOI":"10.3390\/ijms232315039","article-title":"Inflammaging: implications in sarcopenia","volume":"23","author":"Antu\u00f1a","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.117813_b0330","article-title":"The mediating role of inflammaging between mitochondrial dysfunction and sarcopenia in aging: a review","volume":"12(6):109","author":"Xu","year":"2023","journal-title":"Am J Clin Exp Immunol"},{"issue":"2","key":"10.1016\/j.bcp.2026.117813_b0335","doi-asserted-by":"crossref","DOI":"10.1177\/1557988319841934","article-title":"The relation of inflammaging with skeletal muscle properties in elderly men","volume":"13","author":"Zembron-Lacny","year":"2019","journal-title":"Am. J. Mens Health"},{"issue":"56","key":"10.1016\/j.bcp.2026.117813_b0340","article-title":"Inflammaging as a common ground for the development and maintenance of sarcopenia, obesity, cardiomyopathy and dysbiosis","volume":"1","author":"Livshits","year":"2019","journal-title":"Ageing Res. Rev."},{"issue":"8","key":"10.1016\/j.bcp.2026.117813_b0345","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s12603-009-0203-x","article-title":"Physiopathological mechanism of sarcopenia","volume":"13","author":"Boirie","year":"2009","journal-title":"J. Nutr. Health Aging"},{"issue":"3","key":"10.1016\/j.bcp.2026.117813_b0350","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.cger.2011.03.005","article-title":"Physiopathological mechanism of sarcopenia","volume":"27","author":"Walrand","year":"2011","journal-title":"Clin. Geriatr. Med."},{"issue":"4","key":"10.1016\/j.bcp.2026.117813_b0355","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1152\/japplphysiol.00347.2003","article-title":"Invited review: aging and sarcopenia","volume":"95","author":"Doherty","year":"2003","journal-title":"J Appl Physio"},{"key":"10.1016\/j.bcp.2026.117813_b0360","doi-asserted-by":"crossref","unstructured":"Priego T, Mart\u00edn AI, Gonz\u00e1lez-Hedstr\u00f6m D, Granado M, L\u00f3pez-Calder\u00f3n A. Role of hormones in sarcopenia. InVitamins and hormones 2021 Jan 1 (Vol. 115, pp. 535-570). Academic Press. https:\/\/doi.org\/10.1016\/bs.vh.2020.12.021.","DOI":"10.1016\/bs.vh.2020.12.021"},{"key":"10.1016\/j.bcp.2026.117813_b0365","article-title":"The effect of physiological stimuli on sarcopenia; impact of Notch and Wnt signaling on impaired aged skeletal muscle repair","volume":"8(5):731","author":"Arthur","year":"2012","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2026.117813_b0370","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.exger.2003.09.012","article-title":"The contribution of reactive oxygen species to sarcopenia and muscle ageing","volume":"39","author":"Fulle","year":"2004","journal-title":"Exp. Gerontol."},{"issue":"3","key":"10.1016\/j.bcp.2026.117813_b0375","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.cger.2011.03.009","article-title":"Physical activity and sarcopenia","volume":"27","author":"Pillard","year":"2011","journal-title":"Clin. Geriatr. Med."},{"issue":"50","key":"10.1016\/j.bcp.2026.117813_b0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mam.2016.06.001","article-title":"Frailty and sarcopenia as the basis for the phenotypic manifestation of chronic diseases in older adults","volume":"1","author":"Angulo","year":"2016","journal-title":"Mol. Aspects Med."},{"issue":"7","key":"10.1016\/j.bcp.2026.117813_b0385","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/jcsm.12363","article-title":"Cellular and molecular mechanisms of sarcopenia: the S100B perspective","volume":"9","author":"Riuzzi","year":"2018","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"2","key":"10.1016\/j.bcp.2026.117813_b0390","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/jcsm.12937","article-title":"Cell interactome in sarcopenia during aging","volume":"13","author":"Gonz\u00e1lez-Blanco","year":"2022","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"4","key":"10.1016\/j.bcp.2026.117813_b0395","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.3390\/ijms11041509","article-title":"Oxidative stress, molecular inflammation and sarcopenia","volume":"11","author":"Meng","year":"2010","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.bcp.2026.117813_b0400","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3389\/fmed.2019.00184","article-title":"The biological foundations of sarcopenia: established and promising markers","volume":"13","author":"Casati","year":"2019","journal-title":"Front. Med."},{"issue":"2","key":"10.1016\/j.bcp.2026.117813_b0405","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1152\/physiolgenomics.00249.2004","article-title":"Identification of a molecular signature of sarcopenia","volume":"21","author":"Giresi","year":"2005","journal-title":"Physiol. Genomics"},{"issue":"94","key":"10.1016\/j.bcp.2026.117813_b0410","first-page":"155","article-title":"Myokines: the endocrine coupling of skeletal muscle and bone","volume":"1","author":"Gomarasca","year":"2020","journal-title":"Adv. Clin. Chem."},{"issue":"13","key":"10.1016\/j.bcp.2026.117813_b0415","article-title":"Role of myostatin in muscle degeneration by random positioning machine exposure: an in vitro study for the treatment of sarcopenia","volume":"3","author":"Cariati","year":"2022","journal-title":"Front. Physiol."},{"issue":"10","key":"10.1016\/j.bcp.2026.117813_b0420","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.3390\/biomedicines9101301","article-title":"Myostatin and follistatin\u2014new kids on the block in the diagnosis of sarcopenia in IBD and possible therapeutic implications","volume":"9","author":"Skrzypczak","year":"2021","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.bcp.2026.117813_b0425","doi-asserted-by":"crossref","first-page":"28629","DOI":"10.1038\/s41598-024-79534-5","article-title":"Myostatin as a plausible biomarker for early stage of sarcopenic obesity","volume":"14","author":"Ishibashi","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2026.117813_b0430","doi-asserted-by":"crossref","unstructured":"Geladari E, Alexopoulos T, Kontogianni MD, Vasilieva L, Mani I, Alexopoulou A. Mechanisms of sarcopenia in liver cirrhosis and the role of myokines. Ann Gastroenterol. 2023 Jul; 36(4):392. https:\/\/doi.org\/10.20524\/aog.2023.0804.","DOI":"10.20524\/aog.2023.0804"},{"issue":"1","key":"10.1016\/j.bcp.2026.117813_b0435","article-title":"Association between sarcopenia and insulin\u2010like growth factor\u20101, myostatin, and insulin resistance in elderly patients undergoing hemodialysis","volume":"2022","author":"Widajanti","year":"2022","journal-title":"J Aging Res"},{"issue":"17","key":"10.1016\/j.bcp.2026.117813_b0440","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1038\/emboj.2009.205","article-title":"The structure of myostatin: follistatin 288: insights into receptor utilization and heparin binding","volume":"28","author":"Cash","year":"2009","journal-title":"EMBO J."},{"issue":"2","key":"10.1016\/j.bcp.2026.117813_b0445","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1080\/10409238.2019.1610722","article-title":"The role of GDF11 in aging and skeletal muscle, cardiac and bone homeostasis","volume":"54","author":"Egerman","year":"2019","journal-title":"Crit Rev Biochem Mol Bio"},{"issue":"21","key":"10.1016\/j.bcp.2026.117813_b0450","doi-asserted-by":"crossref","first-page":"13180","DOI":"10.3390\/ijms232113180","article-title":"The cytokine growth differentiation factor-15 and skeletal muscle health: portrait of an emerging widely applicable disease biomarker","volume":"23","author":"De Paepe","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.117813_b0455","article-title":"The stress-responsive cytokine GDF-15 and sarcopenia: a systematic review and meta-analysis on aging muscle decline","volume":"26","author":"Papa","year":"2025","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.bcp.2026.117813_b0460","doi-asserted-by":"crossref","unstructured":"Scisciola L, Fontanella RA, Surina, Cataldo V, Paolisso G, Barbieri M. Sarcopenia and cognitive function: role of myokines in muscle brain cross-talk. Life. 2021 Feb 23; 11(2):173. https:\/\/doi.org\/10.3390\/life11020173.","DOI":"10.3390\/life11020173"},{"issue":"2","key":"10.1016\/j.bcp.2026.117813_b0465","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/ijmm.2021.4989","article-title":"Pathophysiology and mechanisms of primary sarcopenia","volume":"48","author":"Nishikawa","year":"2021","journal-title":"Int. J. Mol. Med."},{"issue":"145","key":"10.1016\/j.bcp.2026.117813_b0470","article-title":"Association between serum FGF21 level and sarcopenia in older adults","volume":"1","author":"Jung","year":"2021","journal-title":"Bone"},{"issue":"37","key":"10.1016\/j.bcp.2026.117813_b0475","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2021013118","article-title":"FGF-2\u2013dependent signaling activated in aged human skeletal muscle promotes intramuscular adipogenesis","volume":"118","author":"Mathes","year":"2021","journal-title":"PNAS"},{"issue":"5","key":"10.1016\/j.bcp.2026.117813_b0480","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/dvdy.24495","article-title":"Regulation of skeletal muscle stem cells by fibroblast growth factors","volume":"246","author":"Pawlikowski","year":"2017","journal-title":"Dev. Dyn."},{"issue":"1","key":"10.1016\/j.bcp.2026.117813_b0485","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1152\/japplphysiol.01399.2010","article-title":"LIF is a contraction-induced myokine stimulating human myocyte proliferation","volume":"111","author":"Broholm","year":"2011","journal-title":"J Appl Physio"},{"issue":"2","key":"10.1016\/j.bcp.2026.117813_b0490","doi-asserted-by":"crossref","first-page":"38","DOI":"10.21705\/mcbs.v2i2.32","article-title":"Myokine regulation as marker of sarcopenia in elderly","volume":"2","author":"Aryana","year":"2018","journal-title":"Mol Cell Biomed Sci"},{"issue":"62","key":"10.1016\/j.bcp.2026.117813_b0495","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jare.2023.09.001","article-title":"Irisin as an agent for protecting against osteoporosis: a review of the current mechanisms and pathways","volume":"1","author":"Hu","year":"2024","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.bcp.2026.117813_b0500","doi-asserted-by":"crossref","unstructured":"Posa F, Zerlotin R, Ariano A, Cosola MD, Colaianni G, Fazio AD, Colucci S, Grano M, Mori G. Irisin Role in Chondrocyte 3D Culture Differentiation and Its Possible Applications. Pharmaceutics 2023, 15, 585, 2023 Feb 9; 15 (2):585. https:\/\/doi.org\/10.3390\/pharmaceutics15020585.","DOI":"10.3390\/pharmaceutics15020585"},{"issue":"4","key":"10.1016\/j.bcp.2026.117813_b0505","first-page":"1619","article-title":"Targeting crosstalk of signaling pathways among muscles-bone-adipose tissue: a promising therapeutic approach for sarcopenia","volume":"15","author":"Sharma","year":"2024","journal-title":"Aging Dis."},{"key":"10.1016\/j.bcp.2026.117813_b0510","doi-asserted-by":"crossref","unstructured":"Nakamura SK, Nakano SI, Miyoshi T, Yamanouchi K, Matsuwaki T, Nishihara M. Age-related resistance of skeletal muscle-derived progenitor cells to SPARC may explain a shift from myogenesis to adipogenesis. Aging (Albany NY). 2012 Jan; 4(1):40. https:\/\/doi.org\/10.18632\/aging.100426.","DOI":"10.18632\/aging.100426"},{"issue":"2","key":"10.1016\/j.bcp.2026.117813_b0515","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3390\/metabo12020125","article-title":"Secreted protein acidic and rich in cysteine (Sparc) KO leads to an accelerated ageing phenotype which is improved by exercise whereas SPARC overexpression mimics exercise effects in mice","volume":"12","author":"Ghanemi","year":"2022","journal-title":"Metabolites"},{"issue":"3","key":"10.1016\/j.bcp.2026.117813_b0520","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12954","article-title":"Effects of IGF\u20101 isoforms on muscle growth and sarcopenia","volume":"18","author":"Ascenzi","year":"2019","journal-title":"Aging Cell"},{"key":"10.1016\/j.bcp.2026.117813_b0525","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/978-981-13-1435-3_6","article-title":"The role of IGF-1 signaling in skeletal muscle atrophy","author":"Timmer","year":"2018","journal-title":"Muscle Atrophy"},{"key":"10.1016\/j.bcp.2026.117813_b0530","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12891-020-03236-y","article-title":"Association between sarcopenia and levels of growth hormone and insulin-like growth factor-1 in the elderly","volume":"21","author":"Bian","year":"2020","journal-title":"BMC Musculoskelet. Disord."},{"issue":"22","key":"10.1016\/j.bcp.2026.117813_b0535","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.arr.2015.05.001","article-title":"Sarcopenia\u2013The search for emerging biomarkers","volume":"1","author":"Kalinkovich","year":"2015","journal-title":"Ageing Res. Rev."},{"issue":"1","key":"10.1016\/j.bcp.2026.117813_b0540","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3390\/nu12010261","article-title":"Regulation of skeletal muscle function by amino acids","volume":"12","author":"Kamei","year":"2020","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.bcp.2026.117813_b0545","doi-asserted-by":"crossref","first-page":"17083","DOI":"10.1038\/s41598-023-41628-x","article-title":"\u03b3-Aminobutyric acids (GABA) and serum GABA\/AABA (G\/A) ratio as potential biomarkers of physical performance and aging","volume":"13","author":"Lyssikatos","year":"2023","journal-title":"Sci. Rep."},{"issue":"157","key":"10.1016\/j.bcp.2026.117813_b0550","article-title":"Meteorin-like protein (Metrnl): a metabolic syndrome biomarker and an exercise mediator","volume":"1","author":"Alizadeh","year":"2022","journal-title":"Cytokine"},{"key":"10.1016\/j.bcp.2026.117813_b0555","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.2147\/JIR.S455790","article-title":"The function and mechanism of anti-inflammatory factor metrnl prevents the progression of inflammatory-mediated pathological bone osteolytic diseases","volume":"31","author":"Liu","year":"2024","journal-title":"J. Inflamm. Res."},{"issue":"14","key":"10.1016\/j.bcp.2026.117813_b0560","article-title":"Meteorin-like\/Metrnl, a novel secreted protein implicated in inflammation, immunology, and metabolism: a comprehensive review of preclinical and clinical studies","volume":"24","author":"Li","year":"2023","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.bcp.2026.117813_b0565","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13961","article-title":"AAV\u2010Mediated nuclear localized PGC1\u03b14 delivery in muscle ameliorates sarcopenia and aging\u2010associated metabolic dysfunctions","volume":"22","author":"Guo","year":"2023","journal-title":"Aging Cell"},{"issue":"57","key":"10.1016\/j.bcp.2026.117813_b0570","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jare.2023.04.005","article-title":"Potential nutritional strategies to prevent and reverse sarcopenia in aging process: Role of fish oil-derived \u03c9-3 polyunsaturated fatty acids, wheat oligopeptide and their combined intervention","volume":"1","author":"Pan","year":"2024","journal-title":"J. Adv. Res."},{"issue":"58","key":"10.1016\/j.bcp.2026.117813_b0575","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.exger.2014.07.009","article-title":"Phase angle as bioelectrical marker to identify elderly patients at risk of sarcopenia","volume":"1","author":"Basile","year":"2014","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.bcp.2026.117813_b0580","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s13539-012-0078-2","article-title":"Biomarkers of sarcopenia in clinical trials\u2014recommendations from the International Working Group on Sarcopenia","volume":"3","author":"Cesari","year":"2012","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"4","key":"10.1016\/j.bcp.2026.117813_b0585","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1017\/S0029665112000201","article-title":"Nutrition and sarcopenia: evidence for an interaction","volume":"71","author":"Millward","year":"2012","journal-title":"Proc. Nutr. Soc."},{"issue":"2","key":"10.1016\/j.bcp.2026.117813_b0590","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.abb.2006.11.025","article-title":"Carotenoids as protection against sarcopenia in older adults","volume":"458","author":"Semba","year":"2007","journal-title":"Arch. Biochem. Biophys."},{"issue":"1","key":"10.1016\/j.bcp.2026.117813_b0595","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7239639","article-title":"Exercise modulates oxidative stress and inflammation in aging and cardiovascular diseases","volume":"2016","author":"Sallam","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"154","key":"10.1016\/j.bcp.2026.117813_b0600","article-title":"Inflammation and sarcopenia: a focus on circulating inflammatory cytokines","volume":"15","author":"Pan","year":"2021","journal-title":"Exp. Gerontol."},{"issue":"2","key":"10.1016\/j.bcp.2026.117813_b0605","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3803\/EnM.2013.28.2.86","article-title":"Sarcopenia and sarcopenic obesity","volume":"28","author":"Choi","year":"2013","journal-title":"Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2026.117813_b0610","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1007\/s00018-008-8244-6","article-title":"AMP-activated protein kinase in skeletal muscle: from structure and localization to its role as a master regulator of cellular metabolism","volume":"65","author":"Witczak","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"issue":"3","key":"10.1016\/j.bcp.2026.117813_b0615","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1152\/japplphysiol.00627.2006","article-title":"Sarcopenic obesity and inflammation in the InCHIANTI study","volume":"102","author":"Schrager","year":"2007","journal-title":"J Appl Physio"},{"key":"10.1016\/j.bcp.2026.117813_b0620","first-page":"1","article-title":"Associations of nutritional intake and inflammatory factors with sarcopenia in community-dwelling older adults: a cross-sectional study","volume":"11","author":"Xu","year":"2025","journal-title":"Eur Geriatr Med"},{"key":"10.1016\/j.bcp.2026.117813_b0625","doi-asserted-by":"crossref","unstructured":"Xie R, Yan X, Chen L, Cheng X, Bai L, Li Y, Wang Y, Qiao Y. Relationship of nutritional intake and inflammatory factors with sarcopenia in community-dwelling elderly individuals: A Cross-Sectional Study. Eur Geriatr Med. https:\/\/doi.org\/10.1007\/s41999-024-01147-y.","DOI":"10.1007\/s41999-024-01147-y"},{"issue":"189","key":"10.1016\/j.bcp.2026.117813_b0630","article-title":"Effects of lifelong exercise on age-related body composition, oxidative stress, inflammatory cytokines, and skeletal muscle proteome in rats","volume":"1","author":"Gao","year":"2020","journal-title":"Mech. Ageing Dev."},{"issue":"16","key":"10.1016\/j.bcp.2026.117813_b0635","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.3390\/nu15163529","article-title":"Sex-specific associations between serum IL-16 levels and sarcopenia in older adults","volume":"15","author":"Chen","year":"2023","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.bcp.2026.117813_b0640","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.3390\/ijms25031439","article-title":"NLRP3 contributes to sarcopenia associated to dependency recapitulating inflammatory-associated muscle degeneration","volume":"25","author":"Antu\u00f1a","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2026.117813_b0645","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s12877-023-03938-7","article-title":"The association of dietary inflammatory potential with sarcopenia in Chinese community-dwelling older adults","volume":"23","author":"Bian","year":"2023","journal-title":"BMC Geriatr."},{"issue":"145","key":"10.1016\/j.bcp.2026.117813_b0650","article-title":"Vascular dysfunction as a potential culprit of sarcopenia","volume":"1","author":"Jeon","year":"2021","journal-title":"Exp. Gerontol."},{"issue":"6","key":"10.1016\/j.bcp.2026.117813_b0655","first-page":"1307","article-title":"Ageing-related impairments at the Neuromuscular Junction: nutritional and exercise interventions to attenuate neuromuscular dysfunctions","volume":"10","author":"Rossi","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.bcp.2026.117813_b0660","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s10020-024-00943-3","article-title":"Acetylcholine receptor-\u03b2 inhibition by interleukin-6 in skeletal muscles contributes to modulating neuromuscular junction during aging","volume":"30","author":"Zhao","year":"2024","journal-title":"Mol. Med."},{"issue":"2","key":"10.1016\/j.bcp.2026.117813_b0665","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.ncl.2011.12.012","article-title":"Evaluation of neuromuscular junction disorders in the electromyography laboratory","volume":"30","author":"Juel","year":"2012","journal-title":"Neurol. Clin."},{"issue":"3","key":"10.1016\/j.bcp.2026.117813_b0670","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3390\/biology12030431","article-title":"Upregulation of sarcolemmal hemichannels and inflammatory transcripts with neuromuscular junction instability during lower limb unloading in humans","volume":"12","author":"Sirago","year":"2023","journal-title":"Biology"},{"key":"10.1016\/j.bcp.2026.117813_b0675","first-page":"19","article-title":"Muscle decline in aging and neuromuscular disorders\u2014mechanisms and countermeasures","volume":"379","author":"Kern","year":"2013","journal-title":"Endocrinology"},{"issue":"12","key":"10.1016\/j.bcp.2026.117813_b0680","article-title":"AChRs degeneration at NMJ in aging-associated sarcopenia\u2013a systematic review","volume":"10","author":"Bao","year":"2020","journal-title":"Front. Aging Neurosci."},{"issue":"53","key":"10.1016\/j.bcp.2026.117813_b0685","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nutres.2018.02.006","article-title":"A role for nutritional intervention in addressing the aging neuromuscular junction","volume":"1","author":"Kougias","year":"2018","journal-title":"Nutr. Res."},{"issue":"5","key":"10.1016\/j.bcp.2026.117813_b0690","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/gerona\/glp196","article-title":"Effects of age and sedentary lifestyle on skeletal muscle NF-\u03baB signaling in men","volume":"65","author":"Buford","year":"2010","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"2","key":"10.1016\/j.bcp.2026.117813_b0695","doi-asserted-by":"crossref","first-page":"C317","DOI":"10.1152\/ajpcell.00174.2021","article-title":"Muscle-nerve communication and the molecular assessment of human skeletal muscle denervation with aging","volume":"321","author":"Andersen","year":"2021","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"2","key":"10.1016\/j.bcp.2026.117813_b0700","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3390\/nu17020282","article-title":"Sarcopenia and cardiogeriatrics: the links between skeletal muscle decline and cardiovascular aging","volume":"17","author":"Anagnostou","year":"2025","journal-title":"Nutrients"},{"key":"10.1016\/j.bcp.2026.117813_b0705","doi-asserted-by":"crossref","unstructured":"Akpulat U, Cetiz MV, Baloglu MC, Altunoglu YC, Zengin G. Anti-atrophic Role of Ononis natrix subsp. hispanica Extract in Skeletal Muscle Atrophy: Pathway-targeted Insights and Experimental Validation. Food Biosci. 2025 Jan 25:106000. https:\/\/doi.org\/10.1016\/j.fbio.2025.106000.","DOI":"10.1016\/j.fbio.2025.106000"},{"key":"10.1016\/j.bcp.2026.117813_b0710","doi-asserted-by":"crossref","unstructured":"Springer M, Migliavacca E, Ireland A, Piasecki M, Karaz S, Jacot G, Danenberg E, Raymond F, Descombes P, McPhee JS, Feige JN. A robust neuromuscular system protects rat and human skeletal muscle from sarcopenia. Aging.;8(4). https:\/\/doi.org\/10.18632\/aging.100926.","DOI":"10.18632\/aging.100926"},{"key":"10.1016\/j.bcp.2026.117813_b0715","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.24.20.9079-9091.2004","article-title":"Estrogen-related receptor \u03b1 directs peroxisome proliferator-activated receptor \u03b1 signaling in the transcriptional control of energy metabolism in cardiac and skeletal muscle","author":"Huss","year":"2004","journal-title":"Mol. Cell Biol."},{"issue":"9","key":"10.1016\/j.bcp.2026.117813_b0720","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.3390\/cancers11091264","article-title":"Human cachexia induces changes in mitochondria, autophagy and apoptosis in the skeletal muscle","volume":"11","author":"de Castro","year":"2019","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.bcp.2026.117813_b0725","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1002\/jcp.25260","article-title":"Autophagy as a potential target for sarcopenia","volume":"231","author":"Fan","year":"2016","journal-title":"J. Cell. Physiol."},{"issue":"15","key":"10.1016\/j.bcp.2026.117813_b0730","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.3390\/ijms20153815","article-title":"Dual role of reactive oxygen species in muscle function: can antioxidant dietary supplements counteract age-related sarcopenia?","volume":"20","author":"Damiano","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2026.117813_b0735","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1474-9726.2007.00347.x","article-title":"Mitochondrial function and apoptotic susceptibility in aging skeletal muscle","volume":"7","author":"Chabi","year":"2008","journal-title":"Aging Cell"},{"issue":"1","key":"10.1016\/j.bcp.2026.117813_b0740","article-title":"Proteomic profiling of mitochondrial enzymes during skeletal muscle aging","volume":"2011","author":"Staunton","year":"2011","journal-title":"J Aging Res"},{"issue":"12","key":"10.1016\/j.bcp.2026.117813_b0745","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1016\/j.bbadis.2015.10.002","article-title":"Signaling pathways underlying skeletal muscle wasting in experimental pulmonary arterial hypertension","volume":"1852","author":"Moreira-Gon\u00e7alves","year":"2015","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"issue":"7","key":"10.1016\/j.bcp.2026.117813_b0750","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011468","article-title":"Mitochondrial DNA mutations induce mitochondrial dysfunction, apoptosis and sarcopenia in skeletal muscle of mitochondrial DNA mutator mice","volume":"5","author":"Hiona","year":"2010","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bcp.2026.117813_b0755","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.exger.2007.10.001","article-title":"The role of mitochondrial DNA mutations in aging and sarcopenia: implications for the mitochondrial vicious cycle theory of aging","volume":"43","author":"Hiona","year":"2008","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.bcp.2026.117813_b0760","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00424-005-1473-8","article-title":"Contributions of the ubiquitin\u2013proteasome pathway and apoptosis to human skeletal muscle wasting with age","volume":"450","author":"Whitman","year":"2005","journal-title":"Pflugers Arch."},{"issue":"1","key":"10.1016\/j.bcp.2026.117813_b0765","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3390\/metabo15010059","article-title":"Exerkines and sarcopenia: unveiling the mechanism behind exercise-induced mitochondrial homeostasis","volume":"15","author":"Wang","year":"2025","journal-title":"Metabolites"},{"issue":"5","key":"10.1016\/j.bcp.2026.117813_b0770","article-title":"SPNS1 ablation drives skeletal muscle atrophy by disrupting mitophagy, mitochondrial function, and apoptosis in mice","volume":"11","author":"Zhang","year":"2024","journal-title":"Genes Dis"},{"issue":"6","key":"10.1016\/j.bcp.2026.117813_b0775","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1080\/02841860902974175","article-title":"Apoptosis in cancer: key molecular signaling pathways and therapy targets","volume":"48","author":"Burz","year":"2009","journal-title":"Acta Oncol."},{"issue":"1","key":"10.1016\/j.bcp.2026.117813_b0780","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1432-1033.1996.00001.x","article-title":"Apoptosis: molecular regulation of cell death","volume":"236","author":"Hale","year":"1996","journal-title":"Eur. J. Biochem."},{"issue":"7","key":"10.1016\/j.bcp.2026.117813_b0785","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.3390\/ijms21072346","article-title":"Understanding MAPK signaling pathways in apoptosis","volume":"21","author":"Yue","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.bcp.2026.117813_b0790","first-page":"572","article-title":"Apoptosis: a review of pro\u2010apoptotic and anti\u2010apoptotic pathways and dysregulation in disease","volume":"18","author":"O'Brien","year":"2008","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.117813_b0795","doi-asserted-by":"crossref","DOI":"10.1002\/jcp.31155","article-title":"Augmented mitochondrial apoptotic signaling impairs C2C12 myoblast differentiation following cellular aging through sequential passaging","author":"Rahman","year":"2024","journal-title":"J. Cell. Physiol."},{"issue":"8","key":"10.1016\/j.bcp.2026.117813_b0800","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/jbmr.4021","article-title":"TNF receptor\u2010associated factor 6 mediates TNF\u03b1\u2010induced skeletal muscle atrophy in mice during aging","volume":"35","author":"Li","year":"2020","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.bcp.2026.117813_b0805","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/JES.0b013e318168e9dc","article-title":"Nuclear apoptosis contributes to sarcopenia","volume":"36","author":"Alway","year":"2008","journal-title":"Exerc. Sport Sci. Rev."},{"key":"10.1016\/j.bcp.2026.117813_b0810","doi-asserted-by":"crossref","unstructured":"Sancilio S, Di Pietro R, Mancinelli R, Impicciatore G, Stati G, Fulle S. Caspase-3 is involved in nuclear remodeling of human satellite cells under stress conditions. Apr, 2024. https:\/\/doi.org\/10.21203\/rs.3.rs-4247887\/v1.","DOI":"10.21203\/rs.3.rs-4247887\/v1"},{"issue":"2","key":"10.1016\/j.bcp.2026.117813_b0815","doi-asserted-by":"crossref","first-page":"R519","DOI":"10.1152\/ajpregu.00458.2001","article-title":"Apoptosis in skeletal muscle with aging","volume":"282","author":"Dirks","year":"2002","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.bcp.2026.117813_b0820","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1007\/s10495-006-0194-6","article-title":"Death receptor-associated pro-apoptotic signaling in aged skeletal muscle","volume":"11","author":"Pistilli","year":"2006","journal-title":"Apoptosis"},{"issue":"3\u20134","key":"10.1016\/j.bcp.2026.117813_b0825","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1089\/ars.2006.8.517","article-title":"Exercise training attenuates age-induced changes in apoptotic signaling in rat skeletal muscle","volume":"8","author":"Song","year":"2006","journal-title":"Antioxid. Redox Signal."},{"issue":"1","key":"10.1016\/j.bcp.2026.117813_b0830","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1749-6632.2002.tb02086.x","article-title":"The role of apoptosis in the normal aging brain, skeletal muscle, and heart","volume":"959","author":"Pollack","year":"2002","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2026.117813_b0835","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1113\/jphysiol.2004.081083","article-title":"Mitochondria\u2010associated apoptotic signalling in denervated rat skeletal muscle","volume":"565","author":"Siu","year":"2005","journal-title":"J. Physiol."},{"issue":"1","key":"10.1016\/j.bcp.2026.117813_b0840","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.bbadis.2005.08.003","article-title":"Age-related alterations in expression of apoptosis regulatory proteins and heat shock proteins in rat skeletal muscle","volume":"1762","author":"Chung","year":"2006","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"issue":"5","key":"10.1016\/j.bcp.2026.117813_b0845","doi-asserted-by":"crossref","first-page":"C1105","DOI":"10.1152\/ajpcell.00154.2005","article-title":"Age-related apoptotic responses to stretch-induced hypertrophy in quail slow-tonic skeletal muscle","volume":"289","author":"Siu","year":"2005","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"3","key":"10.1016\/j.bcp.2026.117813_b0850","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1152\/japplphysiol.00768.2006","article-title":"Effect of denervation on mitochondrially mediated apoptosis in skeletal muscle","volume":"102","author":"Adhihetty","year":"2007","journal-title":"J Appl Physio"},{"issue":"9","key":"10.1016\/j.bcp.2026.117813_b0855","doi-asserted-by":"crossref","first-page":"5156","DOI":"10.1073\/pnas.95.9.5156","article-title":"ARC, an inhibitor of apoptosis expressed in skeletal muscle and heart that interacts selectively with caspases","volume":"95","author":"Koseki","year":"1998","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2026.117813_b0860","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s10495-008-0277-7","article-title":"Effect of burn injury on apoptosis and expression of apoptosis-related genes\/proteins in skeletal muscles of rats","volume":"14","author":"Duan","year":"2009","journal-title":"Apoptosis"},{"issue":"3","key":"10.1016\/j.bcp.2026.117813_b0865","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.afos.2017.08.098","article-title":"Molecular mechanisms and therapeutic interventions in sarcopenia","volume":"3","author":"Park","year":"2017","journal-title":"Osteoporosis and Sarcopenia"},{"issue":"3","key":"10.1016\/j.bcp.2026.117813_b0870","doi-asserted-by":"crossref","first-page":"98","DOI":"10.4235\/agmr.19.0028","article-title":"Pharmacological interventions for treatment of sarcopenia: current status of drug development for sarcopenia","volume":"23","author":"Kwak","year":"2019","journal-title":"Ann Geriatr Med Res"},{"issue":"34","key":"10.1016\/j.bcp.2026.117813_b0875","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coph.2017.03.009","article-title":"Skeletal muscle autophagy and its role in sarcopenia and organismal aging","volume":"1","author":"Jiao","year":"2017","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.bcp.2026.117813_b0880","doi-asserted-by":"crossref","unstructured":"Bernabeu-Wittel M, G\u00f3mez-D\u00edaz R, Gonz\u00e1lez-Molina \u00c1, Vidal-Serrano S, D\u00edez-Manglano J, Salgado F, Soto-Mart\u00edn M, Ollero-Baturone M, Proteo Researchers. Oxidative stress, telomere shortening, and apoptosis associated to sarcopenia and frailty in patients with multimorbidity. J Clin Med. 2020 Aug 18; 9(8):2669. https:\/\/doi.org\/10.3390\/jcm9082669.","DOI":"10.3390\/jcm9082669"},{"issue":"5","key":"10.1016\/j.bcp.2026.117813_b0885","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.3892\/ijmm.2014.1675","article-title":"Differential expression of apoptosis-related factors induces the age-related apoptosis of the gracilis muscle in humans","volume":"33","author":"Park","year":"2014","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"10.1016\/j.bcp.2026.117813_b0890","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41420-023-01365-6","article-title":"TNF-\u03b1 contributes to sarcopenia through caspase-8\/caspase-3\/GSDME-mediated pyroptosis","volume":"9","author":"Wu","year":"2023","journal-title":"Cell Death Discov."},{"issue":"6","key":"10.1016\/j.bcp.2026.117813_b0895","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/acel.12399","article-title":"Apoptosis and necrosis mediate skeletal muscle fiber loss in age\u2010induced mitochondrial enzymatic abnormalities","volume":"14","author":"Cheema","year":"2015","journal-title":"Aging Cell"},{"key":"10.1016\/j.bcp.2026.117813_b0900","doi-asserted-by":"crossref","unstructured":"Li FH, Yu HT, Xiao L, Liu YY. Response of BAX, Bcl-2 proteins, and SIRT1\/PGC-1\u03b1 mRNA expression to 8-week treadmill running in the aging rat skeletal muscle. InOxygen Transport to Tissue XXXVIII 2016 (pp. 283-289). Springer International Publishing. https:\/\/doi.org\/10.1007\/978-3-319-38810-6_38.","DOI":"10.1007\/978-3-319-38810-6_38"},{"issue":"11","key":"10.1016\/j.bcp.2026.117813_b0905","article-title":"Exercise-induced autophagy suppresses sarcopenia through Akt\/mTOR and Akt\/FoxO3a signal pathways and AMPK-mediated mitochondrial quality control","volume":"2","author":"Zeng","year":"2020","journal-title":"Front. Physiol."},{"issue":"1","key":"10.1016\/j.bcp.2026.117813_b0910","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12844","article-title":"Aging differentially modulates the Wnt pro\u2010survival signalling pathways in vascular smooth muscle cells","volume":"18","author":"Brown","year":"2019","journal-title":"Aging Cell"},{"issue":"5","key":"10.1016\/j.bcp.2026.117813_b0915","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.tem.2008.12.005","article-title":"Hsps and aging","volume":"20","author":"Tower","year":"2009","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.bcp.2026.117813_b0920","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12979-023-00381-5","article-title":"Bifidobacterium bifidum and Lactobacillus paracasei alleviate sarcopenia and cognitive impairment in aged mice by regulating gut microbiota-mediated AKT, NF-\u03baB, and FOXO3a signaling pathways","volume":"20","author":"Baek","year":"2023","journal-title":"Immun. Ageing"},{"key":"10.1016\/j.bcp.2026.117813_b0925","doi-asserted-by":"crossref","first-page":"827","DOI":"10.2147\/CIA.S455736","article-title":"Non-pharmacological strategies for managing sarcopenia in chronic diseases","volume":"31","author":"Hu","year":"2024","journal-title":"Clin. Interv. Aging"},{"issue":"3","key":"10.1016\/j.bcp.2026.117813_b0930","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jamda.2019.12.012","article-title":"Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment","volume":"21","author":"Chen","year":"2020","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"10.1016\/j.bcp.2026.117813_b0935","doi-asserted-by":"crossref","unstructured":"Wu WY, Dong JJ, Huang XC, Chen ZJ, Chen XL, Dong QT, Bai YY. AWGS2019 vs EWGSOP2 for diagnosing sarcopenia to predict long-term prognosis in Chinese patients with gastric cancer after radical gastrectomy. World Journal of Clinical Cases. 2021 Jun 26;9(18):4668. https:\/\/doi.org\/10.12998\/wjcc.v9.i18.4668.","DOI":"10.12998\/wjcc.v9.i18.4668"},{"issue":"3","key":"10.1016\/j.bcp.2026.117813_b0940","doi-asserted-by":"crossref","first-page":"436","DOI":"10.3390\/nu16030436","article-title":"Diagnostic criteria and measurement techniques of sarcopenia: a critical evaluation of the up-to-date evidence","volume":"16","author":"Voulgaridou","year":"2024","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.bcp.2026.117813_b0945","first-page":"547","article-title":"The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates","volume":"69","author":"Studenski","year":"2014","journal-title":"J. Gerontol. Ser. A Biomed. Sci. Med. Sci."},{"issue":"4","key":"10.1016\/j.bcp.2026.117813_b0950","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1007\/s00330-019-06573-2","article-title":"Imaging of sarcopenia: old evidence and new insights","volume":"30","author":"Albano","year":"2020","journal-title":"Eur. Radiol."},{"issue":"11","key":"10.1016\/j.bcp.2026.117813_b0955","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1038\/oby.2010.5","article-title":"Comparison of DXA and CT in the assessment of body composition in premenopausal women with obesity and anorexia nervosa","volume":"18","author":"Bredella","year":"2010","journal-title":"Obesity"},{"issue":"2","key":"10.1016\/j.bcp.2026.117813_b0960","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/jcsm.12258","article-title":"Computed tomography diagnosed cachexia and sarcopenia in 725 oncology patients: is nutritional screening capturing hidden malnutrition?","volume":"9","author":"N\u00ed Bhuachalla","year":"2018","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"7","key":"10.1016\/j.bcp.2026.117813_b0965","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/gerona\/gly183","article-title":"Opportunistic measurement of skeletal muscle size and muscle attenuation on computed tomography predicts 1-year mortality in medicare patients","volume":"74","author":"Lenchik","year":"2019","journal-title":"J. Gerontol.: Ser. A"},{"issue":"6","key":"10.1016\/j.bcp.2026.117813_b0970","article-title":"Advancements in sarcopenia diagnosis: from imaging techniques to non-radiation assessments","volume":"9","author":"Lavalle","year":"2024","journal-title":"Front. Med. Technol."},{"issue":"9","key":"10.1016\/j.bcp.2026.117813_b0975","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.3390\/nu14091817","article-title":"The effect of non-pharmacological and pharmacological interventions on measures associated with sarcopenia in end-stage kidney disease: a systematic review and meta-analysis","volume":"14","author":"March","year":"2022","journal-title":"Nutrients"},{"issue":"112","key":"10.1016\/j.bcp.2026.117813_b0980","article-title":"Non-pharmacological interventions for community-dwelling older adults with possible sarcopenia or sarcopenia: a scoping review","volume":"1","author":"Shi","year":"2023","journal-title":"Arch. Gerontol. Geriatr."},{"issue":"5","key":"10.1016\/j.bcp.2026.117813_b0985","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.ajcnut.2023.08.015","article-title":"The role of nutrition in the prevention of sarcopenia","volume":"118","author":"Robinson","year":"2023","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.bcp.2026.117813_b0990","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s40520-016-0709-0","article-title":"Nutrition, frailty, and sarcopenia","volume":"29","author":"Cruz-Jentoft","year":"2017","journal-title":"Aging Clin. Exp. Res."},{"issue":"3","key":"10.1016\/j.bcp.2026.117813_b0995","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3390\/diseases10030042","article-title":"Nutritional and nutrition-related biomarkers as prognostic factors of sarcopenia, and their role in disease progression","volume":"10","author":"Papadopoulou","year":"2022","journal-title":"Diseases"},{"issue":"11","key":"10.1016\/j.bcp.2026.117813_b1000","article-title":"Associations of micronutrient dietary patterns with sarcopenia among US adults: a population-based study","volume":"12","author":"Liu","year":"2024","journal-title":"Front. Nutr."},{"issue":"18","key":"10.1016\/j.bcp.2026.117813_b1005","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.3390\/nu15184073","article-title":"Anabolic resistance in the pathogenesis of sarcopenia in the elderly: role of nutrition and exercise in young and old people","volume":"15","author":"Tezze","year":"2023","journal-title":"Nutrients"},{"issue":"11","key":"10.1016\/j.bcp.2026.117813_b1010","article-title":"Role of nutrition in skeletal muscle atrophy and sarcopenia","volume":"3","author":"Tong","year":"2024","journal-title":"Front. Nutr."},{"key":"10.1016\/j.bcp.2026.117813_b1015","doi-asserted-by":"crossref","unstructured":"Xie WQ, Xiao WF, Tang K, Wu YX, Hu PW, Li YS, Duan Y, Lv S. Caloric restriction: implications for sarcopenia and potential mechanisms. Aging (albany NY). 2020 Dec 12; 12(23):24441. https:\/\/doi.org\/10.18632\/aging.103987.","DOI":"10.18632\/aging.103987"},{"issue":"12","key":"10.1016\/j.bcp.2026.117813_b1020","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1093\/nutrit\/nuaa145","article-title":"Comparison of calorie and nutrient intake among elderly with and without sarcopenia: a systematic review and meta-analysis","volume":"79","author":"Santiago","year":"2021","journal-title":"Nutr. Rev."},{"issue":"6","key":"10.1016\/j.bcp.2026.117813_b1025","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1002\/jcsm.13057","article-title":"The beneficial therapeutic effects of plant\u2010derived natural products for the treatment of sarcopenia","volume":"13","author":"Bagherniya","year":"2022","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"41","key":"10.1016\/j.bcp.2026.117813_b1030","article-title":"Plant-based medicines in the treatment of cardiometabolic disorders: a special view on sarcopenic obesity","volume":"1","author":"Sabarathinam","year":"2023","journal-title":"Obes Med"},{"issue":"7","key":"10.1016\/j.bcp.2026.117813_b1035","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/gerona\/glr047","article-title":"Long-term supplementation with resveratrol alleviates oxidative stress but does not attenuate sarcopenia in aged mice","volume":"66","author":"Jackson","year":"2011","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"3","key":"10.1016\/j.bcp.2026.117813_b1040","first-page":"101","article-title":"Combination of exercise training and resveratrol attenuates obese sarcopenia in skeletal muscle atrophy","volume":"63","author":"Bai","year":"2020","journal-title":"J Physiol Investig"},{"issue":"12","key":"10.1016\/j.bcp.2026.117813_b1045","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.3390\/nu11122861","article-title":"Vitamin D deficiency and sarcopenia in older persons","volume":"11","author":"Remelli","year":"2019","journal-title":"Nutrients"},{"issue":"10","key":"10.1016\/j.bcp.2026.117813_b1050","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.3390\/nu13103589","article-title":"The optimal strategy of vitamin d for sarcopenia: a network meta-analysis of randomized controlled trials","volume":"13","author":"Cheng","year":"2021","journal-title":"Nutrients"},{"issue":"14","key":"10.1016\/j.bcp.2026.117813_b1055","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.1021\/acs.jafc.0c00688","article-title":"Protein nutritional support: the classical and potential new mechanisms in the prevention and therapy of sarcopenia","volume":"68","author":"Zhang","year":"2020","journal-title":"J. Agric. Food Chem."},{"issue":"1","key":"10.1016\/j.bcp.2026.117813_b1060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jnutbio.2009.06.014","article-title":"Dietary implications on mechanisms of sarcopenia: roles of protein, amino acids and antioxidants","volume":"21","author":"Kim","year":"2010","journal-title":"J. Nutr. Biochem."},{"issue":"19","key":"10.1016\/j.bcp.2026.117813_b1065","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.3390\/nu16193271","article-title":"Emerging targets and treatments for sarcopenia: a narrative review","volume":"16","author":"Cacciatore","year":"2024","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.bcp.2026.117813_b1070","doi-asserted-by":"crossref","first-page":"551","DOI":"10.12965\/jer.1836268.134","article-title":"Role of exercise in age-related sarcopenia","volume":"14","author":"Yoo","year":"2018","journal-title":"J Exerc Rehabil"},{"issue":"Supplement","key":"10.1016\/j.bcp.2026.117813_b1075","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.3177\/jnsv.61.S125","article-title":"Role of exercise and nutrition in the prevention of sarcopenia","volume":"61","author":"Makanae","year":"2015","journal-title":"J. Nutr. Sci. Vitaminol."},{"issue":"3","key":"10.1016\/j.bcp.2026.117813_b1080","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3390\/jfmk8030092","article-title":"A systematic review and meta-analysis of exercise beneficial for locomotion in community-dwelling elderly people with sarcopenia","volume":"8","author":"Song","year":"2023","journal-title":"J Funct Morphol Kinesiol"},{"key":"10.1016\/j.bcp.2026.117813_b1085","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s40520-016-0705-4","article-title":"Physical activity and exercise as countermeasures to physical frailty and sarcopenia","volume":"29","author":"Marzetti","year":"2017","journal-title":"Aging Clin. Exp. Res."},{"issue":"7","key":"10.1016\/j.bcp.2026.117813_b1090","doi-asserted-by":"crossref","first-page":"e8307","DOI":"10.15252\/emmm.201708307","article-title":"The AMPK agonist 5\u2010aminoimidazole\u20104\u2010carboxamide ribonucleotide (AICAR), but not metformin, prevents inflammation\u2010associated cachectic muscle wasting","volume":"10","author":"Hall","year":"2018","journal-title":"EMBO Mol. Med."},{"issue":"18","key":"10.1016\/j.bcp.2026.117813_b1095","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.3390\/nu16183097","article-title":"Functional role of extracellular vesicles in skeletal muscle physiology and sarcopenia: the importance of physical exercise and nutrition","volume":"16","author":"Lombardo","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.bcp.2026.117813_b1100","first-page":"1","article-title":"Understanding of sarcopenia: from definition to therapeutic strategies","volume":"1","author":"Kim","year":"2021","journal-title":"Arch. Pharm. Res."},{"issue":"1","key":"10.1016\/j.bcp.2026.117813_b1105","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1891\/0198-8794.36.205","article-title":"Resistance exercise to prevent and manage sarcopenia and dynapenia","volume":"36","author":"Clark","year":"2016","journal-title":"Annu. Rev. Gerontol. Geriatr."},{"issue":"3","key":"10.1016\/j.bcp.2026.117813_b1110","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/gerona\/gln050","article-title":"Skeletal muscle hypertrophy following resistance training is accompanied by a fiber type\u2013specific increase in satellite cell content in elderly men","volume":"64","author":"Verdijk","year":"2009","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2026.117813_b1115","article-title":"Resistance training and sarcopenia","volume":"84","author":"Giallauria","year":"2015","journal-title":"Monaldi Arch. Chest Dis."},{"key":"10.1016\/j.bcp.2026.117813_b1120","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s10549-016-3900-2","article-title":"Impact of resistance and aerobic exercise on sarcopenia and dynapenia in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial","volume":"158","author":"Adams","year":"2016","journal-title":"Breast Cancer Res. Treat."},{"issue":"5","key":"10.1016\/j.bcp.2026.117813_b1125","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3390\/metabo11050323","article-title":"Lifelong aerobic exercise alleviates sarcopenia by activating autophagy and inhibiting protein degradation via the AMPK\/PGC-1\u03b1 signaling pathway","volume":"11","author":"Liang","year":"2021","journal-title":"Metabolites"},{"issue":"37","key":"10.1016\/j.bcp.2026.117813_b1130","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000039472","article-title":"Clinical effect of anti-resistance exercise combined with nutritional intervention in the treatment of elderly patients with sarcopenia","volume":"103","author":"Chen","year":"2024","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.bcp.2026.117813_b1135","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1749-6632.1998.tb09918.x","article-title":"Combined exercise and dietary intervention to optimize body composition in aging","volume":"854","author":"Singh","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"5","key":"10.1016\/j.bcp.2026.117813_b1140","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s11914-022-00739-6","article-title":"Exercise and exercise mimetics for the treatment of musculoskeletal disorders","volume":"20","author":"Cento","year":"2022","journal-title":"Curr. Osteoporos. Rep."},{"issue":"4","key":"10.1016\/j.bcp.2026.117813_b1145","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1249\/JSR.0b013e3181e93938","article-title":"Endurance exercise mimetics in skeletal muscle","volume":"9","author":"Matsakas","year":"2010","journal-title":"Curr. Sports Med. Rep."},{"issue":"5","key":"10.1016\/j.bcp.2026.117813_b1150","doi-asserted-by":"crossref","first-page":"58","DOI":"10.14797\/mdcvj.1304","article-title":"Exercise and ischemia-activated pathways in limb muscle angiogenesis and vascular regeneration","volume":"19","author":"Narkar","year":"2023","journal-title":"Methodist Debakey Cardiovasc. J."},{"issue":"4","key":"10.1016\/j.bcp.2026.117813_b1155","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3803\/EnM.2020.405","article-title":"Sarcopenia and muscle aging: a brief overview","volume":"35","author":"Dao","year":"2020","journal-title":"Endocrinol. Metab."},{"issue":"220","key":"10.1016\/j.bcp.2026.117813_b1160","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.freeradbiomed.2024.04.231","article-title":"Carbon monoxide-loaded cell therapy as an exercise mimetic for sarcopenia treatment","volume":"1","author":"Noguchi","year":"2024","journal-title":"Free Radic. Biol. Med."},{"issue":"9","key":"10.1016\/j.bcp.2026.117813_b1165","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.23812","article-title":"The influential responsibility of sirtuins in senescence and associated diseases: a review","volume":"38","author":"Mishra","year":"2024","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"1","key":"10.1016\/j.bcp.2026.117813_b1170","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2141\/jpsa.0210021","article-title":"AMP-activated protein kinase activation suppresses protein synthesis and mTORC1 signaling in chick myotube cultures","volume":"59","author":"Nakashima","year":"2022","journal-title":"J. Poult. Sci."},{"issue":"10","key":"10.1016\/j.bcp.2026.117813_b1175","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13334","article-title":"Implications of NAD+ boosters in translational medicine","volume":"50","author":"Kang","year":"2020","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.bcp.2026.117813_b1180","doi-asserted-by":"crossref","unstructured":"Alpay F. Boosting NAD+ for Anti-Aging: Mechanisms, Interventions, and Opportunities. https:\/\/doi.org\/10.26434\/chemrxiv-2025-nl80r.","DOI":"10.26434\/chemrxiv-2025-nl80r"},{"issue":"3","key":"10.1016\/j.bcp.2026.117813_b1185","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3803\/EnM.2021.1081","article-title":"Receptor-mediated muscle homeostasis as a target for sarcopenia therapeutics","volume":"36","author":"Yoon","year":"2021","journal-title":"Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.bcp.2026.117813_b1190","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.celrep.2019.07.043","article-title":"Nicotinamide riboside augments the aged human skeletal muscle NAD+ metabolome and induces transcriptomic and anti-inflammatory signatures","volume":"28","author":"Elhassan","year":"2019","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.bcp.2026.117813_b1195","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s42255-024-00997-x","article-title":"Trigonelline is an NAD+ precursor that improves muscle function during ageing and is reduced in human sarcopenia","volume":"6","author":"Membrez","year":"2024","journal-title":"Nat Metab"},{"issue":"6","key":"10.1016\/j.bcp.2026.117813_b1200","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.cmet.2016.09.013","article-title":"Long-term administration of nicotinamide mononucleotide mitigates age-associated physiological decline in mice","volume":"24","author":"Mills","year":"2016","journal-title":"Cell Metab."},{"issue":"5","key":"10.1016\/j.bcp.2026.117813_b1205","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1080\/13813455.2019.1638414","article-title":"Nicotinamide protects against skeletal muscle atrophy in streptozotocin-induced diabetic mice","volume":"125","author":"Guo","year":"2019","journal-title":"Arch. Physiol. Biochem."},{"key":"10.1016\/j.bcp.2026.117813_b1210","article-title":"NAD+: an Old but Promising Therapeutic Agent for Skeletal Muscle Ageing","volume":"30","author":"Xu","year":"2023","journal-title":"Ageing Res. Rev."},{"issue":"72","key":"10.1016\/j.bcp.2026.117813_b1215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.36150\/2499-6564-N695","article-title":"The aging muscle: sarcopenia, mitochondrial function, and redox biology","volume":"25","author":"Buglio","year":"2024","journal-title":"J Gerontol Geriatr"},{"issue":"13","key":"10.1016\/j.bcp.2026.117813_b1220","article-title":"The regulatory network of potential transcription factors and MiRNAs of mitochondria-related genes for sarcopenia","volume":"12","author":"Fu","year":"2022","journal-title":"Front. Genet."},{"issue":"97","key":"10.1016\/j.bcp.2026.117813_b1225","article-title":"Frontiers in sarcopenia: Advancements in diagnostics, molecular mechanisms, and therapeutic strategies","volume":"1","author":"Liu","year":"2024","journal-title":"Mol. Aspects Med."},{"issue":"9","key":"10.1016\/j.bcp.2026.117813_b1230","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1080\/87559129.2023.2274487","article-title":"Phytonutrients as potential dietary supplements to ameliorate sarcopenia via the involvement of autophagic pathway","volume":"40","author":"Sun","year":"2024","journal-title":"Food Rev. Int."},{"issue":"2","key":"10.1016\/j.bcp.2026.117813_b1235","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000330064","article-title":"Apoptosis in skeletal myocytes: a potential target for interventions against sarcopenia and physical frailty\u2013a mini-review","volume":"58","author":"Marzetti","year":"2012","journal-title":"Gerontology"},{"issue":"4","key":"10.1016\/j.bcp.2026.117813_b1240","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2174\/1573399810666140918121022","article-title":"Effects of the antidiabetic drugs on the age-related atrophy and sarcopenia associated with diabetes type II","volume":"10","author":"Cetrone","year":"2014","journal-title":"Curr. Diabetes Rev."},{"issue":"176","key":"10.1016\/j.bcp.2026.117813_b1245","article-title":"Novel drug targets and molecular mechanisms for sarcopenia based on systems biology","volume":"1","author":"Ceyhan","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"11","key":"10.1016\/j.bcp.2026.117813_b1250","doi-asserted-by":"crossref","first-page":"M999","DOI":"10.1093\/gerona\/58.11.M999","article-title":"Role of apoptosis in sarcopenia","volume":"58","author":"Leeuwenburgh","year":"2003","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2026.117813_b1255","article-title":"Sarcopenia and age\u2010related endocrine function","volume":"2012","author":"Sakuma","year":"2012","journal-title":"Int. J. Endocrinol."},{"issue":"10","key":"10.1016\/j.bcp.2026.117813_b1260","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209488","article-title":"What is the role of the sympathetic system in skeletal muscle?","volume":"102","author":"Benarroch","year":"2024","journal-title":"Neurology"},{"issue":"19","key":"10.1016\/j.bcp.2026.117813_b1265","doi-asserted-by":"crossref","first-page":"10795","DOI":"10.3390\/ijms221910795","article-title":"The ryanodine receptor as a sensor for intracellular environments in muscles","volume":"22","author":"Kobayashi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.bcp.2026.117813_b1270","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1089\/hum.2017.158","article-title":"Systemic SMAD7 gene therapy increases striated muscle mass and enhances exercise capacity in a dose-dependent manner","volume":"29","author":"Maricelli","year":"2018","journal-title":"Hum. Gene Ther."},{"issue":"47","key":"10.1016\/j.bcp.2026.117813_b1275","doi-asserted-by":"crossref","first-page":"12448","DOI":"10.1073\/pnas.1707925114","article-title":"Blockade of activin type II receptors with a dual anti-ActRIIA\/IIB antibody is critical to promote maximal skeletal muscle hypertrophy","volume":"114","author":"Morvan","year":"2017","journal-title":"PNAS"},{"issue":"24","key":"10.1016\/j.bcp.2026.117813_b1280","doi-asserted-by":"crossref","first-page":"9599","DOI":"10.3390\/ijms21249599","article-title":"Small molecules acting on myofilaments as treatments for heart and skeletal muscle diseases","volume":"21","author":"Alsulami","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.117813_b1285","doi-asserted-by":"crossref","unstructured":"Dioh W, Narkar V, Singh A, Malik F, Ferrucci L, Tourette C, Mariani J, van Maanen R, Fielding RA. Novel Potential Targets for Function-Promoting Therapies: Orphan Nuclear Receptors, Anti-inflammatory Drugs, Troponin Activators, Mas Receptor Agonists, and Urolithin A. J Gerontol A Biol Sci Med Sci. 2023 Jun 1; 78(Supplement_1):44-52. https:\/\/doi.org\/10.1093\/gerona\/glad072.","DOI":"10.1093\/gerona\/glad072"},{"issue":"2","key":"10.1016\/j.bcp.2026.117813_b1290","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3390\/jox13020017","article-title":"Systematic review of safety of selective androgen receptor modulators in healthy adults: implications for recreational users","volume":"13","author":"Vignali","year":"2023","journal-title":"J Xenobiot"},{"issue":"1","key":"10.1016\/j.bcp.2026.117813_b1295","article-title":"Selective androgen receptor modulators (SARMs): a mini-review","volume":"1","author":"Naafs","year":"2018","journal-title":"Open Access J Reprod Syst Sex Disord"},{"issue":"8","key":"10.1016\/j.bcp.2026.117813_b1300","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1038\/s41591-022-01923-y","article-title":"Cellular senescence and senolytics: the path to the clinic","volume":"28","author":"Chaib","year":"2022","journal-title":"Nat. Med."},{"issue":"200","key":"10.1016\/j.bcp.2026.117813_b1305","article-title":"Skeletal muscle aging, cellular senescence, and senotherapeutics: current knowledge and future directions","volume":"1","author":"Englund","year":"2021","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.bcp.2026.117813_b1310","doi-asserted-by":"crossref","unstructured":"Sierra-Ramirez A, L\u00f3pez-Aceituno JL, Costa-Machado LF, Plaza A, Barradas M, Fernandez-Marcos PJ. Transient metabolic improvement in obese mice treated with navitoclax or dasatinib\/quercetin. Aging (Albany NY). 2020 Jun 25;12(12):11337. https:\/\/doi.org\/10.18632\/aging.103607.","DOI":"10.18632\/aging.103607"},{"issue":"2","key":"10.1016\/j.bcp.2026.117813_b1315","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13767","article-title":"Senolytic drugs, dasatinib and quercetin, attenuate adipose tissue inflammation, and ameliorate metabolic function in old age","volume":"22","author":"Islam","year":"2023","journal-title":"Aging Cell"},{"key":"10.1016\/j.bcp.2026.117813_b1320","doi-asserted-by":"crossref","DOI":"10.1152\/japplphysiol.00080.2007","article-title":"Role of myokines in exercise and metabolism","author":"Pedersen","year":"2007","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.bcp.2026.117813_b1325","first-page":"1","article-title":"Therapeutic applications and challenges in myostatin inhibition for enhanced skeletal muscle mass and functions","volume":"28","author":"Wetzlich","year":"2024","journal-title":"Mol. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.bcp.2026.117813_b1330","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1210\/endrev\/bnab030","article-title":"Myostatin\/activin receptor ligands in muscle and the development status of attenuating drugs","volume":"43","author":"Rodgers","year":"2022","journal-title":"Endocr. Rev."},{"issue":"1","key":"10.1016\/j.bcp.2026.117813_b1335","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/1987218","article-title":"Increased circulating levels of interleukin\u20106 induce perturbation in redox\u2010regulated signaling cascades in muscle of dystrophic mice","volume":"2017","author":"Pelosi","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"7","key":"10.1016\/j.bcp.2026.117813_b1340","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/nmo.12803","article-title":"In vivo neutralization of IL\u20106 receptors ameliorates gastrointestinal dysfunction in dystrophin\u2010deficient mdx mice","volume":"28","author":"Manning","year":"2016","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.bcp.2026.117813_b1345","doi-asserted-by":"crossref","unstructured":"Bian AL, Hu HY, Rong YD, Wang J, Wang JX, Zhou XZ. A study on relationship between elderly sarcopenia and inflammatory factors IL-6 and TNF-\u03b1. Eur J Med Res. 2017 Jul 12;22(1):25. https:\/\/doi.org\/110.1186\/s40001-017-0266-9.","DOI":"10.1186\/s40001-017-0266-9"},{"key":"10.1016\/j.bcp.2026.117813_b1350","doi-asserted-by":"crossref","unstructured":"Hein TR, Peterson L, Bartikoski BJ, Portes J, Espirito Santo RC, Xavier RM. The effect of disease-modifying anti-rheumatic drugs on skeletal muscle mass in rheumatoid arthritis patients: a systematic review with meta-analysis. Arthritis Res Ther. 2022 Jul 19;24(1):171.https:\/\/doi.org\/10.1186\/s13075-022-02858-y.","DOI":"10.1186\/s13075-022-02932-5"},{"issue":"9","key":"10.1016\/j.bcp.2026.117813_b1355","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1111\/jgs.14927","article-title":"Treatment of sarcopenia with bimagrumab: results from a phase II, randomized, controlled, proof\u2010of\u2010concept study","volume":"65","author":"Rooks","year":"2017","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.bcp.2026.117813_b1360","unstructured":"Regeneron Pharmaceuticals. A Study to Assess Safety, Tolerability and Efficacy of Garetosmab Versus Placebo Administered Intravenously (IV) in Adult Participants With Fibrodysplasia Ossificans Progressiva (FOP) (OPTIMA). ClinicalTrials.gov [Internet]. Identifier NCT05394116, 2022 May 27 [cited 2026 Jan 12]. Available from: https:\/\/www.clinicaltrials.gov\/study\/NCT05394116."},{"key":"10.1016\/j.bcp.2026.117813_b1365","doi-asserted-by":"crossref","unstructured":"Attie KM, Borgstein NG, Yang Y, et al. A single ascending- dose study of muscle regulator ACE- 031 in healthy volunteers. Muscle Nerve. 2013;47:416- 423.https:\/\/doi.org\/10.1002\/mus.23539.","DOI":"10.1002\/mus.23539"},{"key":"10.1016\/j.bcp.2026.117813_b1370","unstructured":"Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp & Dohme, a subsidiary of Merck & Co., Inc.). A Study of ACE-2494 in Healthy Subjects. ClinicalTrials.gov [Internet]. Updated 2019 Jul 16 [cited 2026 Jan 12]. Identifier NCT03478319. Available from: https:\/\/clinicaltrials.gov\/study\/NCT03478319."},{"issue":"6","key":"10.1016\/j.bcp.2026.117813_b1375","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/mus.26113","article-title":"Locally acting ACE- 083 increases muscle volume in healthy volunteers","volume":"57","author":"Glasser","year":"2018","journal-title":"Muscle Nerve"},{"issue":"4","key":"10.1016\/j.bcp.2026.117813_b1380","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.ymthe.2017.02.015","article-title":"Follistatin gene therapy for sporadic inclusion body myositis improves functional outcomes","volume":"25","author":"Mendell","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bcp.2026.117813_b1385","unstructured":"Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia [Internet]. ClinicalTrials.gov, NCT01963598; 2013\u20132015. Sponsored by Regeneron Pharmaceuticals (Information provided by Regeneron Pharmaceuticals) [cited 2026 Jan 12]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01963598."},{"issue":"12","key":"10.1016\/j.bcp.2026.117813_b1390","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/S2213-8587(15)00298-3","article-title":"Myostatin antibody (LY2495655) in older weak fallers: a proof- of- concept, randomised, phase 2 trial","volume":"3","author":"Becker","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"5","key":"10.1016\/j.bcp.2026.117813_b1395","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/apt.13058","article-title":"Infliximab reverses inflammatory muscle wasting (sarcopenia) in Crohn's disease","volume":"41","author":"Subramaniam","year":"2015","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.bcp.2026.117813_b1400","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003884","article-title":"Long-term clinical outcomes of certolizumab pegol treatment in non-radiographic axial spondyloarthritis stratified by baseline MRI and CRP status","volume":"10","author":"Rudwaleit","year":"2024","journal-title":"RMD Open"},{"key":"10.1016\/j.bcp.2026.117813_b1405","article-title":"Skeletal muscle effects of Janus kinase inhibition in rheumatoid arthritis (RAMUS): a single-arm, experimental medicine study","author":"Bennett","year":"2025","journal-title":"Lancet Rheumatol."},{"issue":"84","key":"10.1016\/j.bcp.2026.117813_b1410","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/j.ard.2025.06.1490","article-title":"ABS0161 weight and muscle gain in patients with rheumatoid arthritis treated with baricitinib may reflect an improvement in sarcopenia","volume":"1","author":"Garufi","year":"2025","journal-title":"Ann. Rheum. Dis."},{"issue":"12","key":"10.1016\/j.bcp.2026.117813_b1415","article-title":"The role and mechanisms of myokines in sarcopenia: new intervention strategies for the challenges of aging","volume":"9","author":"Cui","year":"2025","journal-title":"Front. Med."},{"issue":"24","key":"10.1016\/j.bcp.2026.117813_b1420","article-title":"626. Directing skeletal myogenic progenitor cell lineage specification with CRISPR\/Cas9 transcriptional activators","volume":"1","author":"Kwon","year":"2016","journal-title":"Mol. Ther."},{"issue":"23","key":"10.1016\/j.bcp.2026.117813_b1425","doi-asserted-by":"crossref","first-page":"8625","DOI":"10.3390\/molecules27238625","article-title":"Zebrafish models for skeletal muscle senescence: lessons from cell cultures and rodent models","volume":"27","author":"Ichii","year":"2022","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.bcp.2026.117813_b1430","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.cmet.2008.10.003","article-title":"Apelin stimulates glucose utilization in normal and obese insulin-resistant mice","volume":"8","author":"Dray","year":"2008","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.bcp.2026.117813_b1435","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2337\/db11-0100","article-title":"Apelin treatment increases complete fatty acid oxidation, mitochondrial oxidative capacity, and biogenesis in muscle of insulin-resistant mice","volume":"61","author":"Attan\u00e9","year":"2012","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.bcp.2026.117813_b1440","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1038\/s41591-018-0131-6","article-title":"The exerkine apelin reverses age-associated sarcopenia","volume":"24","author":"Vinel","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcp.2026.117813_b1445","doi-asserted-by":"crossref","unstructured":"Tian X, Pan M, Zhou M, Tang Q, Chen M, Hong W, Zhao F, Liu K. Mitochondria transplantation from stem cells for mitigating sarcopenia. Aging Dis. 2023 Oct 1;14(5):1700.119. https:\/\/doi.org\/10.14336\/AD.2023.0210.","DOI":"10.14336\/AD.2023.0210"},{"issue":"5","key":"10.1016\/j.bcp.2026.117813_b1450","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41419-023-05843-8","article-title":"Clinical-grade human umbilical cord-derived mesenchymal stem cells improved skeletal muscle dysfunction in age-associated sarcopenia mice","volume":"14","author":"Wang","year":"2023","journal-title":"Cell Death Dis."},{"issue":"47","key":"10.1016\/j.bcp.2026.117813_b1455","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.copbio.2017.05.003","article-title":"Biomaterials for skeletal muscle tissue engineering","volume":"1","author":"Kwee","year":"2017","journal-title":"Curr. Opin. Biotechnol."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2026.117813_b1460","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1089\/ten.tea.2020.0005","article-title":"Bioengineered skeletal muscle as a model of muscle aging and regeneration","volume":"27","author":"Rajabian","year":"2021","journal-title":"Tissue Eng. A"},{"issue":"11","key":"10.1016\/j.bcp.2026.117813_b1465","article-title":"Porous biomaterial scaffolds for skeletal muscle tissue engineering","volume":"3","author":"Kozan","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.bcp.2026.117813_b1470","article-title":"Nanotechnology empowering biomedical therapy: new treatment perspectives for sarcopenia and degenerative muscle atrophy","author":"Liu","year":"2026","journal-title":"Biomater. Sci."},{"issue":"12","key":"10.1016\/j.bcp.2026.117813_b1475","article-title":"Mechanisms linking the gut-muscle axis with muscle protein metabolism and anabolic resistance: implications for older adults at risk of sarcopenia","volume":"26","author":"Prokopidis","year":"2021","journal-title":"Front. Physiol."},{"issue":"10","key":"10.1016\/j.bcp.2026.117813_b1480","doi-asserted-by":"crossref","first-page":"e1053","DOI":"10.1002\/ctm2.1053","article-title":"The bacterial quorum sensing peptide iAM373 is a novel inducer of sarcopenia","volume":"12","author":"De Spiegeleer","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.bcp.2026.117813_b1485","unstructured":"Veritus Research. A Randomized, Phase 1, Double-blind, Placebo-Controlled, 2-Part, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects of KER-065 Administered to Healthy Adult Volunteers. Australian New Zealand Clinical Trials Registry Identifier ACTRN12623001233617. Australian New Zealand Clinical Trials Registry. Updated 11 March 2025. Available online: https:\/\/www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=386654 (accessed on 15 September 2025)."},{"key":"10.1016\/j.bcp.2026.117813_b1490","unstructured":"Rejuvenate Bio, Inc. A Phase 1B, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RJx-01 in Elderly Subjects With Sarcopenia. ClinicalTrials.gov Identifier NCT05401944. ClinicalTrials.gov. Updated 22 June 2022. Available online: https:\/\/clinicaltrials.gov\/study\/NCT05401944 (accessed on 15 September 2025)."},{"key":"10.1016\/j.bcp.2026.117813_b1495","unstructured":"Lipocine, Inc. A Study to Evaluate the Efficacy and Safety of LPCN 1148 in Male Subjects With Cirrhosis and Sarcopenia (LiFT). ClinicalTrials.gov Identifier NCT04874350. ClinicalTrials.gov. Updated 25 July 2025. Available online: https:\/\/clinicaltrials.gov\/study\/NCT04874350 (accessed on 15 September 2025)."},{"key":"10.1016\/j.bcp.2026.117813_b1500","unstructured":"Novartis. Dose Range Finding Study of Bimagrumab in Sarcopenia. ClinicalTrials.gov Identifier NCT02333331. ClinicalTrials.gov. Updated 5 January 2021. Available online: https:\/\/clinicaltrials.gov\/study\/NCT02333331 (accessed on 15 September 2025)."},{"key":"10.1016\/j.bcp.2026.117813_b1505","unstructured":"University of New Mexico. A Pilot Study to Assess the Effects of Losartan on Physical Performance in Sarcopenic Elderly. ClinicalTrials.gov Identifier NCT01989793. ClinicalTrials.gov. Updated 25 February 2016. Available online: https:\/\/clinicaltrials.gov\/study\/NCT01989793 (accessed on 15 September 2025)."},{"key":"10.1016\/j.bcp.2026.117813_b1510","unstructured":"Integrated Physical Training With Protein Diet in Older Adults. ClinicalTrials.gov Identifier: NCT05224453. ClinicalTrials.gov. Updated [date when last update]. Available online: https:\/\/clinicaltrials.gov\/study\/NCT05224453 (accessed on 15 September 2025)."},{"key":"10.1016\/j.bcp.2026.117813_b1515","unstructured":"Chang Gung University of Science and Technology. Effects of Integrated Exercise on Sarcopenia, Depression Symptoms, and Quality of Life. ClinicalTrials.gov Identifier NCT06637228. ClinicalTrials.gov. Updated 15 October 2024. Available online: https:\/\/clinicaltrials.gov\/study\/NCT06637228 (accessed on 15 September 2025)."},{"key":"10.1016\/j.bcp.2026.117813_b1520","unstructured":"University of Illinois at Chicago. The Impact of a Resistance Training Intervention on Blood Pressure Control in Older Adults With Sarcopenia (INERTIA). ClinicalTrials.gov Identifier NCT04255745. ClinicalTrials.gov. Updated 28 August 2025. Available online: https:\/\/clinicaltrials.gov\/study\/NCT04255745 (accessed on 15 September 2025)."},{"key":"10.1016\/j.bcp.2026.117813_b1525","unstructured":"Seoul Bumin Hospital. Combined Exercise and Nutrition Intervention for Sarcopenia. ClinicalTrials.gov Identifier NCT06654648. ClinicalTrials.gov. Updated 24 October 2024. Available online: https:\/\/clinicaltrials.gov\/study\/NCT06654648 (accessed on 15 September 2025)."},{"key":"10.1016\/j.bcp.2026.117813_b1530","unstructured":"Prince Sattam Bin Abdulaziz University. Integrated Physical Training With Protein Diet in Older Adults With Sarcopenia Symptoms [Internet]. ClinicalTrials.gov identifier: NCT05224453. Bethesda (MD): U.S. National Library of Medicine. 2022 Feb 4 [cited 2025 Sep 15]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05224453."},{"key":"10.1016\/j.bcp.2026.117813_b1535","unstructured":"University of Melbourne. Protein and Resistance Training in Aged Care to Counteract Sarcopenia (PROT-AGE Study) [Internet]. ClinicalTrials.gov identifier: NCT02628145. Bethesda (MD): U.S. National Library of Medicine. 2015 Dec 9 [cited 2025 Sep 15]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT02628145."},{"key":"10.1016\/j.bcp.2026.117813_b1540","unstructured":"University of Valencia. Sarcopenia Cut-points and Functionality in Older Adults (SARCOFUNC). ClinicalTrials.gov Identifier NCT03832608. ClinicalTrials.gov. Updated 3 May 2021. Available online: https:\/\/clinicaltrials.gov\/study\/NCT03832608 (accessed on 15 September 2025)."},{"key":"10.1016\/j.bcp.2026.117813_b1545","unstructured":"Geriatric Core of Research of the State University of Rio de Janeiro. Validation of SARC-F for Sarcopenia's Screening in Different Clinical Scenarios. ClinicalTrials.gov Identifier NCT03021798. ClinicalTrials.gov. Updated 12 July 2017. Available online: https:\/\/clinicaltrials.gov\/study\/NCT03021798 (accessed on 15 September 2025)."},{"issue":"76","key":"10.1016\/j.bcp.2026.117813_b1550","article-title":"Multi-omics research in sarcopenia: current progress and future prospects","volume":"1","author":"Liu","year":"2022","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.bcp.2026.117813_b1555","doi-asserted-by":"crossref","unstructured":"Lamaudiere M, Sergaki C. Appropriate Biological Standardisation to Bring Confidence to Omics Data: The Example of the Microbiome. Food Science and Nutrition Cases. 2024 Jul 24(2024):fsncases20240004. https:\/\/doi.org\/10.1079\/fsncases.2024.0004.","DOI":"10.1079\/fsncases.2024.0004"},{"issue":"1","key":"10.1016\/j.bcp.2026.117813_b1560","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/ageing\/afy106","article-title":"The prevalence of sarcopenia in community-dwelling older adults, an exploration of differences between studies and within definitions: a systematic review and meta-analyses","volume":"48","author":"Mayhew","year":"2019","journal-title":"Age Ageing"},{"issue":"10","key":"10.1016\/j.bcp.2026.117813_b1565","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1007\/s40520-023-02496-7","article-title":"Exploring the variability of sarcopenia prevalence in a research population using different disease definitions","volume":"35","author":"Cegielski","year":"2023","journal-title":"Aging Clin. Exp. Res."},{"key":"10.1016\/j.bcp.2026.117813_b1570","doi-asserted-by":"crossref","DOI":"10.1016\/j.afos.2025.05.005","article-title":"Sarcopenia prevention in older adults: Effectiveness and limitations of non-pharmacological interventions","author":"Kim","year":"2025","journal-title":"Osteoporosis and Sarcopenia"},{"issue":"1","key":"10.1016\/j.bcp.2026.117813_b1575","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/jcsm.12783","article-title":"Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta\u2010analysis","volume":"13","author":"Petermann-Rocha","year":"2022","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"17","key":"10.1016\/j.bcp.2026.117813_b1580","doi-asserted-by":"crossref","first-page":"8527","DOI":"10.3390\/ijms26178527","article-title":"Unravelling the complexity of sarcopenia through a systems biology approach","volume":"26","author":"Ceyhan","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.117813_b1585","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2147\/CIA.S438144","article-title":"Obstacles to the early diagnosis and management of sarcopenia: current perspectives","volume":"31","author":"Ooi","year":"2024","journal-title":"Clin. Interv. Aging"},{"issue":"1","key":"10.1016\/j.bcp.2026.117813_b1590","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1186\/s12967-025-06575-3","article-title":"Biomarkers for sarcopenia, muscle mass, muscle strength, and physical performance: an umbrella review","volume":"23","author":"Liu","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bcp.2026.117813_b1595","doi-asserted-by":"crossref","unstructured":"Garcia-Diez AI, Porta-Vilaro M, Isern-Kebschull J, Naude N, Guggenberger R, Brugnara L, Milinkovic A, Bartolome-Solanas A, Soler-Perromat JC, Del Amo M, Novials A. Myosteatosis: diagnostic significance and assessment by imaging approaches. Quantitative Imaging in Medicine and Surgery. 2024 Oct 8;14(11):7937. https:\/\/doi.org\/10.21037\/qims-24-365.","DOI":"10.21037\/qims-24-365"},{"issue":"4","key":"10.1016\/j.bcp.2026.117813_b1600","doi-asserted-by":"crossref","DOI":"10.1093\/gerona\/glad280","article-title":"Estimating muscle mass using D3-creatine dilution: a narrative review of clinical implications and comparison with other methods","volume":"79","author":"Pagano","year":"2024","journal-title":"J. Gerontol., Series A: Biol. Sci. Med. Sci."},{"key":"10.1016\/j.bcp.2026.117813_b1605","doi-asserted-by":"crossref","first-page":"98","DOI":"10.4235\/agmr.19.0028","article-title":"Pharmacological interventions for treatment of sarcopenia: current status of drug development for sarcopenia","volume":"23","author":"Kwak","year":"2019","journal-title":"Ann Geriatr Med Res"},{"key":"10.1016\/j.bcp.2026.117813_b1610","article-title":"Personalised nutrition and health","volume":"361","author":"Ordovas","year":"2018","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.bcp.2026.117813_b1615","doi-asserted-by":"crossref","first-page":"98","DOI":"10.4235\/agmr.19.0028","article-title":"Pharmacological interventions for treatment of sarcopenia: current status of drug development for sarcopenia","volume":"23","author":"Kwak","year":"2019","journal-title":"Annals of Geriatric Medicine and Research"},{"key":"10.1016\/j.bcp.2026.117813_b1620","doi-asserted-by":"crossref","unstructured":"Seok M, Kim W. Sarcopenia prediction for elderly people using machine learning: A case study on physical activity. InHealthcare 2023 May 5 (Vol. 11, No. 9, p. 1334). MDPI. https:\/\/doi.org\/10.3390\/healthcare11091334.","DOI":"10.3390\/healthcare11091334"},{"key":"10.1016\/j.bcp.2026.117813_b1625","doi-asserted-by":"crossref","unstructured":"Micheel CM, Nass SJ, Omenn GS, Committee on the Review of Omics-Based Tests for Predicting Patient Outcomes in Clinical Trials. Omics-based clinical discovery: Science, technology, and applications. InEvolution of Translational Omics: Lessons Learned and the Path Forward 2012 Mar 23. National Academies Press (US).","DOI":"10.17226\/13297"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226001449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226001449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T02:49:05Z","timestamp":1777430945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226001449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":325,"alternative-id":["S0006295226001449"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117813","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sarcopenia: An overview of emerging therapies and pathophysiological insights in age-related skeletal muscle decline","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117813","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117813"}}